Protocadherins

Protocadherins are a large group of cell adhesion molecules in the cadherin superfamily that function in calcium-dependent cell–cell adhesion. They are predominantly expressed in the vertebrate nervous system and are distinguished by their highly diverse extracellular domains and variable expression patterns.

Genetic organization: clustered protocadherins are encoded by three gene clusters (PCDHα, PCDHβ, PCDHγ) on chromosome 5 in humans. Each gene typically contains a promoter that drives expression of a variable exon, which splices to a common constant region to produce a unique extracellular and membrane-tethered isoform. This architecture allows extensive combinatorial diversity, generating hundreds of protocadherin isoforms through promoter choice and alternative splicing.

Function: in brain development, protocadherins contribute to neuronal self-avoidance, dendritic arborization, and synaptic specificity, by enabling homophilic interactions that help distinguish neighboring neurons. The prevailing view is that each neuron expresses a distinctive set of protocadherin isoforms; matching isoforms promote adhesion and synaptic connections, while non-matching isoforms reduce adhesion, influencing neural circuit formation.

Clinical significance: alterations in protocadherin genes, including mutations and epigenetic changes, have been associated with neurodevelopmental disorders such as autism spectrum conditions and intellectual disability, as well as with cancer in some contexts. Ongoing research aims to clarify their signaling interactions with intracellular scaffolding proteins and their precise roles in neural connectivity.